scispace - formally typeset
S

Stephen O'Rahilly

Researcher at University of Cambridge

Publications -  537
Citations -  81904

Stephen O'Rahilly is an academic researcher from University of Cambridge. The author has contributed to research in topics: Insulin resistance & Insulin. The author has an hindex of 138, co-authored 520 publications receiving 75686 citations. Previous affiliations of Stephen O'Rahilly include Dana Corporation & University of Oxford.

Papers
More filters
Journal ArticleDOI

WNT10B mutations in human obesity

TL;DR: While the pedigree analysis in the case of C256Y WNT10B does not provide definitive proof of a causal link of this variant with obesity, the finding of a non-functioning WNT 10B allele in a human family affected by obesity should encourage further study of this gene in other obese populations.
Journal ArticleDOI

Leptin predicts a worsening of the features of the metabolic syndrome independently of obesity.

TL;DR: This study used a prospective population-based cohort of 748 middle-aged whites to test the hypothesis that leptin predicts the development of the features of MS independently of obesity.
Journal ArticleDOI

The Link Between Nutritional Status and Insulin Sensitivity Is Dependent on the Adipocyte-Specific Peroxisome Proliferator–Activated Receptor-γ2 Isoform

TL;DR: The results indicate that insulin resistance associated with ablation of PPARgamma2 is not the result of lipodystrophy and suggests a specific role for PPAR Gamma2 in maintaining insulin sensitivity independently of its effects on adipogenesis, and raises the intriguing notion that PPARGamma2 may be necessary for the adverse effects of a high-fat diet on carbohydrate metabolism.
Journal ArticleDOI

C/EBP transcription factors regulate SREBP1c gene expression during adipogenesis.

TL;DR: In this paper, C/EBPα was shown to be a regulator of SREBP1c expression in maturing adipocytes using shRNA (short hairpin RNA) and ChIP assays.
Journal ArticleDOI

A Genome-Wide Association Study Reveals Variants in ARL15 that Influence Adiponectin Levels

J. Brent Richards, +69 more
- 11 Dec 2009 - 
TL;DR: A novel protein is identified, ARL15, which influences circulating adiponectin levels and may impact upon CHD risk, and several metabolic traits are identified.